{"AllianceGenome": "1513", "HGNC": "1513", "MIM": "114251", "_id": "845", "_version": 1, "accession": {"genomic": ["AL449264.18", "AL450389.12", "CH471122.1", "CP068277.2", "HF583635.1", "NC_000001.11", "NC_060925.1", "NG_008802.1"], "protein": ["AAH22288.1", "BAA23494.1", "BAG35873.1", "BAG57061.1", "BAG58422.1", "BDY34016.1", "CCQ43132.1", "EAW56635.1", "EAW56636.1", "NP_001223.2", "O14958.2"], "rna": ["AK129831.1", "AK129891.1", "AK225959.1", "AK293595.1", "AK295502.1", "AK313041.1", "BC022288.1", "BM679349.1", "D55655.1", "DC423064.1", "LC760317.1", "NM_001232.4"], "translation": [{"protein": "AAH22288.1", "rna": "BC022288.1"}, {"protein": "BAG57061.1", "rna": "AK293595.1"}, {"protein": "BAG35873.1", "rna": "AK313041.1"}, {"protein": "BAG58422.1", "rna": "AK295502.1"}, {"protein": "BDY34016.1", "rna": "LC760317.1"}, {"protein": "BAA23494.1", "rna": "D55655.1"}, {"protein": "NP_001223.2", "rna": "NM_001232.4"}]}, "alias": "PDIB2", "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "moderate", "classification_date": "2021-01-20T17:00:00.000Z", "disease_label": "catecholaminergic polymorphic ventricular tachycardia", "gcep": "Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0017990", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c778b145-fcfc-4252-8dd8-33f982b288e8-2021-01-20T170000.000Z", "sop": "SOP7"}, {"classification": "definitive", "classification_date": "2021-01-20T17:00:00.000Z", "disease_label": "catecholaminergic polymorphic ventricular tachycardia", "gcep": "Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0017990", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_991ee32e-280d-4bea-a638-aa1b6fa6f781-2021-01-20T170000.000Z", "sop": "SOP7"}, {"classification": "disputed", "classification_date": "2022-05-10T16:00:00.000Z", "disease_label": "hypertrophic cardiomyopathy", "gcep": "Hereditary Cardiovascular Disease Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005045", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07177c89-7845-4df5-ba3e-bdd415b5c8b3-2022-05-10T160000.000Z", "sop": "SOP9"}]}, "ensembl": {"gene": "ENSG00000118729", "protein": ["ENSP00000261448", "ENSP00000518226", "ENSP00000519014", "ENSP00000519015", "ENSP00000519016", "ENSP00000519031", "ENSP00000519032", "ENSP00000519033"], "transcript": ["ENST00000261448", "ENST00000488931", "ENST00000713711", "ENST00000713712", "ENST00000713713", "ENST00000713727", "ENST00000713728", "ENST00000713729"], "translation": [{"protein": "ENSP00000519014", "rna": "ENST00000713711"}, {"protein": "ENSP00000261448", "rna": "ENST00000261448"}, {"protein": "ENSP00000519031", "rna": "ENST00000713727"}, {"protein": "ENSP00000518226", "rna": "ENST00000488931"}, {"protein": "ENSP00000519032", "rna": "ENST00000713728"}, {"protein": "ENSP00000519033", "rna": "ENST00000713729"}, {"protein": "ENSP00000519015", "rna": "ENST00000713712"}, {"protein": "ENSP00000519016", "rna": "ENST00000713713"}], "type_of_gene": "protein_coding"}, "entrezgene": "845", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 14.5833009613, "exp_mis": 122.615076373, "exp_syn": 55.4606464908, "lof_z": 0.929490703982748, "mis_z": -1.07712344180216, "mu_lof": 9.29139800222e-07, "mu_mis": 1.07974489678e-05, "mu_syn": 4.66345955485e-06, "n_lof": 11.0, "n_mis": 147.0, "n_syn": 58.0, "p_li": 1.06548301273598e-06, "p_null": 0.44590646463471, "p_rec": 0.554092469882277, "syn_z": -0.21138762645626}, "bp": 1200, "cds_end": 116311162, "cds_start": 116243861, "n_exons": 11, "nonpsych": {"exp_lof": 12.9812093041, "exp_mis": 110.760394031, "exp_syn": 49.9791555309, "lof_z": 1.08519915737456, "mis_z": -0.778295905466513, "mu_lof": 9.29139800222e-07, "mu_mis": 1.07974489678e-05, "mu_syn": 4.66345955485e-06, "n_lof": 9.0, "n_mis": 127.0, "n_syn": 49.0, "p_li": 2.32298931252296e-05, "p_null": 0.290410433005067, "p_rec": 0.709566337101808, "syn_z": 0.0872012410715618}, "nontcga": {"exp_lof": 13.3953796165, "exp_mis": 112.784620436, "exp_syn": 51.0025430725, "lof_z": 0.645621672164563, "mis_z": -1.04217007803339, "mu_lof": 9.29139800222e-07, "mu_mis": 1.07974489678e-05, "mu_syn": 4.66345955485e-06, "n_lof": 11.0, "n_mis": 135.0, "n_syn": 55.0, "p_li": 5.27803414701044e-07, "p_null": 0.589079807542252, "p_rec": 0.410919664654334, "syn_z": -0.354413728042736}, "transcript": "ENST00000261448.5"}, "exons": [{"cdsend": 115768541, "cdsstart": 115701240, "chr": "1", "position": [[115700020, 115701426], [115702920, 115702995], [115705191, 115705292], [115717839, 115717894], [115725507, 115725553], [115726991, 115727122], [115732900, 115732974], [115738223, 115738335], [115740727, 115740828], [115744827, 115744912], [115768307, 115768714]], "strand": -1, "transcript": "NM_001232", "txend": 115768714, "txstart": 115700020}], "exons_hg19": [{"cdsend": 116311162, "cdsstart": 116243861, "chr": "1", "position": [[116242641, 116244047], [116245541, 116245616], [116247812, 116247913], [116260460, 116260515], [116268128, 116268174], [116269612, 116269743], [116275521, 116275595], [116280844, 116280956], [116283348, 116283449], [116287448, 116287533], [116310928, 116311335]], "strand": -1, "transcript": "NM_001232", "txend": 116311335, "txstart": 116242641}], "generif": [{"pubmed": 11704930, "text": "missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel"}, {"pubmed": 12386154, "text": "calsequestrin 2 mutations causes severe forms of catecholaminergic polymorphic ventricular tachycardia"}, {"pubmed": 12732448, "text": "missense mutation in the CASQ2 gene is associated with autosomal-recessive CPVT(catecholamine-induced polymorphic ventricular tachycardia)."}, {"pubmed": 12858557, "text": "A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel."}, {"pubmed": 16601229, "text": "Intracellular Ca2+ cycling in normal heart relies on intricate interplay of CASQ2 with proteins of RyR2 channel complex, and disruption of these interactions can lead to cardiac arrhythmia."}, {"pubmed": 16908766, "text": "CASQ2 mutations identified in polymorphic ventricular tachycardia create distinct abnormalities that lead to abnormal intracellular calcium regulation, thus facilitating the development of tachyarrhythmias."}, {"pubmed": 17045261, "text": "CSQ was a highly phosphorylated protein with a glycan structure predictive of ER-retained proteins."}, {"pubmed": 17655857, "text": "A variant was identified in CASQ2."}, {"pubmed": 17881003, "text": "Data show that all three CPVT-related missense mutations lead to significant reduction in Ca2+-binding capacity and scattering experiments confirm that the linear polymerization behavior of CSQ is linked directly to its high-capacity Ca2+ binding."}, {"pubmed": 18399795, "text": "analysis of how human and rat CASQ2 ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity"}, {"pubmed": 18469084, "text": "study concludes CASQ2 in the sarcoplasmic reticulum (SR )determines magnitude & duration of Ca release from each SR terminal; 2 CPVT-inducing CASQ2 mutations lead to increased diastolic SR Ca release events and exhibit a similar CPVT disease phenotype"}, {"pubmed": 18543230, "text": "A novel mutation of F189L in the CASQ2 gene was identified in families with catecholaminergic polymorphic ventricular tachycardia."}, {"pubmed": 18669926, "text": "REVIEW of Casq2 mutations that cause catecholaminergic polymorphic ventricular tachycardia and their effects on Casq2 function and Ca handling"}, {"pubmed": 19357236, "text": "Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression."}, {"pubmed": 19376574, "text": "Data suggest that calsequestrin (CSQ)2 facilitates Ca(2+) release through RyR2 during systole, while CSQ1 curtails RyR1 opening to maintain Ca(2+) and allow repeated release/ graded activation with increased stimulation frequency."}, {"pubmed": 19398665, "text": "Cardiac and fatal or near-fatal events were not rare in both catecholaminergic polymorphic ventricular tachycardia RYR2 and a CASQ2 mutation probands and affected family members during the long-term follow-up"}, {"pubmed": 19709828, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20039900, "text": "up-regulation of casq2 gene in the thyroid of patients with Graves' Hyperthyroidism may lead to the production of autoantibodies and sensitized T-lymphocytes, which cross-react with calsequestrin of patients who develop ophthalmopathy."}, {"pubmed": 20302875, "text": "The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling."}, {"pubmed": 21063088, "text": "A regulatory role of CASQ2 on cytosolic Ca(2+) and hERG channels which may contribute to the etiology of CPVT."}, {"pubmed": 21265816, "text": "Catecholaminergic polymorphic ventricular tachycardia (CPTV) mutations modify CASQ2 behaviour, including folding, aggregation/polymerization and selectivity towards Ca2+."}, {"pubmed": 21416293, "text": "Studies identified two phosphorylation sites, Ser(385) and Ser(393 in hCASQ2 by mass-spectroscopy."}, {"pubmed": 21618644, "text": "Molecular analysis of the CASQ2 gene in 43 probands with Catecholaminergic polymorphic ventricular tachycardia were performed and eight mutations in five patients, were identified."}, {"pubmed": 21685173, "text": "Common variations in or near CASQ2, GPD1L, and NOS1AP are associated with increased risk of sudden cardiac death in patients with coronary artery disease"}, {"pubmed": 21872879, "text": "Two causative genes of CPVT have been identified: RYR2, encoding the cardiac ryanodine receptor (RyR2) Ca(2+) release channel, and CASQ2, encoding cardiac calsequestrin. Their mutation have been found in 60% of patients with CPVT."}, {"pubmed": 22050625, "text": "Aspartate to histidine casq2 mutation causes arrhythmia in cardiomyocytes generated from catecholaminergic polymorphic ventricular tachycardia patients."}, {"pubmed": 22123818, "text": "Ca(2+) and JNT-dependent disassembly of the CSQ2 polymer"}, {"pubmed": 22421959, "text": "A review of the physiology of Casq2 in cardiac Ca2+ handling and discuss pathophysiological mechanisms that lead to catecholaminergic polymorphic ventricular tachycardia caused by CASQ2 mutations."}, {"pubmed": 22481011, "text": "patients with CASQ2-associated CPVT should be recommended to receive ICDs to prevent sudden death when medical therapy is not effective."}, {"pubmed": 22650415, "text": "In a consanguineous family, a novel homozygous CASQ2 mutation (p.L77P) was identified in a child with CPVT who required implantation of a cardioverter defibrillator due to episodes of syncope while on medical therapy"}, {"pubmed": 23595086, "text": "Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan."}, {"pubmed": 24127619, "text": "The sarcoplasmic reticulum calcium content in human type II fibres is primarily determined by the CSQ1 abundance, and in type I fibres, by the combined amounts of both CSQ1 and CSQ2."}, {"pubmed": 24444446, "text": "We observed association between a CASQ2 polymorphism and SCA due to VA in patients with CAD adjusting for CHF and independent associations between CASQ2 SNPs and CHF adjusting for SCA."}, {"pubmed": 25892673, "text": "Mutations in the MYBPC3 and CASQ2 genes and six combinations between loci in the MYBPC3, MYH7 and CASQ2 genes were responsible for cardiomyopathy risk in a studied cohort."}, {"pubmed": 26153920, "text": "induced Pluripotent Stem Cell-derived cardiomyocytes are useful for investigating the similarities/differences in the pathophysiological consequences of RyR2 versus CASQ2 mutations underlying Catecholaminergic polymorphic ventricular tachycardia."}, {"pubmed": 27157848, "text": "We show for the first time a heterozygous CASQ2 variant causing autosomal dominant CPVT in a large family with a severe phenotype."}, {"pubmed": 27609834, "text": "a direct interaction exists between RyR2 and CSQ2, is reported."}, {"pubmed": 31482657, "text": "CASQ2 variants are associated with catecholaminergic polymorphic ventricular tachycardia."}, {"pubmed": 31934898, "text": "Catecholaminergic Polymorphic Ventricular Tachycardia."}, {"pubmed": 32291483, "text": "Association of T66A polymorphism in CASQ2 with PR interval in a Chinese population.\", trans \"Assoziation des T66A-Polymorphismus im CASQ2-Gen mit dem PR-Intervall in einer chinesischen Population."}, {"pubmed": 32693635, "text": "An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia."}, {"pubmed": 32902830, "text": "Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants."}, {"pubmed": 33046906, "text": "The structure of a calsequestrin filament reveals mechanisms of familial arrhythmia."}, {"pubmed": 34743414, "text": "Calsequestrin 2 overexpression in breast cancer increases tumorigenesis and metastasis by modulating the tumor microenvironment."}], "genomic_pos": {"chr": "1", "end": 115793195, "ensemblgene": "ENSG00000118729", "start": 115698038, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 116311402, "start": 116242628, "strand": -1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0002027", "pubmed": [15485681, 16601229, 16908766], "qualifier": "involved_in", "term": "regulation of heart rate"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0005513", "pubmed": 22123818, "qualifier": "involved_in", "term": "detection of calcium ion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006874", "pubmed": 16908766, "qualifier": "involved_in", "term": "intracellular calcium ion homeostasis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006941", "pubmed": 9795116, "qualifier": "involved_in", "term": "striated muscle contraction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010649", "pubmed": 16908766, "qualifier": "involved_in", "term": "regulation of cell communication by electrical coupling"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010880", "qualifier": "involved_in", "term": "regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0010881", "qualifier": "involved_in", "term": "regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010881", "pubmed": [16601229, 16908766], "qualifier": "involved_in", "term": "regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043267", "pubmed": 21063088, "qualifier": "involved_in", "term": "negative regulation of potassium ion transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051208", "pubmed": 16601229, "qualifier": "involved_in", "term": "sequestering of calcium ion"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051258", "pubmed": [17881003, 22123818], "qualifier": "involved_in", "term": "protein polymerization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060048", "pubmed": 16908766, "qualifier": "involved_in", "term": "cardiac muscle contraction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060306", "pubmed": 21063088, "qualifier": "involved_in", "term": "regulation of membrane repolarization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060315", "pubmed": 16601229, "qualifier": "involved_in", "term": "negative regulation of ryanodine-sensitive calcium-release channel activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060315", "qualifier": "involved_in", "term": "negative regulation of ryanodine-sensitive calcium-release channel activity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071313", "pubmed": 16908766, "qualifier": "involved_in", "term": "cellular response to caffeine"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0086029", "pubmed": 22198169, "qualifier": "involved_in", "term": "Purkinje myocyte to ventricular cardiac muscle cell signaling"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1901017", "pubmed": 21063088, "qualifier": "involved_in", "term": "negative regulation of potassium ion transmembrane transporter activity"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 22123818, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0014701", "pubmed": 17569730, "qualifier": "located_in", "term": "junctional sarcoplasmic reticulum membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0016529", "qualifier": "located_in", "term": "sarcoplasmic reticulum"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0030018", "qualifier": "is_active_in", "term": "Z disc"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0030018", "qualifier": "located_in", "term": "Z disc"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0033017", "qualifier": "located_in", "term": "sarcoplasmic reticulum membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0033018", "qualifier": "is_active_in", "term": "sarcoplasmic reticulum lumen"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0033018", "pubmed": 16908766, "qualifier": "located_in", "term": "sarcoplasmic reticulum lumen"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0034704", "pubmed": 19403607, "qualifier": "part_of", "term": "calcium channel complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005509", "qualifier": "enables", "term": "calcium ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005509", "pubmed": [16601229, 16908766, 17881003], "qualifier": "enables", "term": "calcium ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [22123818, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0042803", "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0048306", "pubmed": 15485681, "qualifier": "enables", "term": "calcium-dependent protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0140314", "pubmed": 21416293, "qualifier": "enables", "term": "calcium ion sequestering activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0140314", "pubmed": 16908766, "qualifier": "enables", "term": "calcium ion sequestering activity"}]}, "homologene": {"genes": [[7955, 114410], [8364, 394741], [9031, 395198], [9598, 457150], [9606, 845], [9615, 483134], [9913, 528555], [10090, 12373], [10116, 29209]], "id": 20330}, "interpro": [{"desc": "Calsequestrin", "id": "IPR001393", "short_desc": "Calsequestrin"}, {"desc": "Calsequestrin, conserved site", "id": "IPR018233", "short_desc": "Calsequestrin_CS"}, {"desc": "Thioredoxin-like superfamily", "id": "IPR036249", "short_desc": "Thioredoxin-like_sf"}, {"desc": "Calsequestrin, middle TRX-fold domain", "id": "IPR041858", "short_desc": "Calsequestrin_middle_dom"}, {"desc": "Calsequestrin, N-terminal TRX-fold domain", "id": "IPR041859", "short_desc": "Calsequestrin_N"}, {"desc": "Calsequestrin, C-terminal TRX-fold domain", "id": "IPR041860", "short_desc": "Calsequestrin_C"}], "ipi": ["IPI00298933", "IPI00908384", "IPI00909474"], "map_location": "1p13.1", "name": "calsequestrin 2", "other_names": ["calsequestrin 2 (cardiac muscle)", "calsequestrin 2, fast-twitch, cardiac muscle", "calsequestrin-2"], "pantherdb": {"HGNC": "1513", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1309469", "ortholog_type": "LDO", "panther_family": "PTHR10033", "taxid": 10090, "uniprot_kb": "O09161"}, {"RGD": "2276", "ortholog_type": "LDO", "panther_family": "PTHR10033", "taxid": 10116, "uniprot_kb": "P51868"}, {"Gene": "CASQ2", "ortholog_type": "O", "panther_family": "PTHR10033", "taxid": 9031, "uniprot_kb": "P19204"}, {"Ensembl": "ENSGALG00000015018", "ortholog_type": "LDO", "panther_family": "PTHR10033", "taxid": 9031, "uniprot_kb": "F1NQT9"}, {"ZFIN": "ZDB-GENE-010724-12", "ortholog_type": "LDO", "panther_family": "PTHR10033", "taxid": 7955, "uniprot_kb": "Q6DI16"}, {"WormBase": "WBGene00000822", "ortholog_type": "O", "panther_family": "PTHR10033", "taxid": 6239, "uniprot_kb": "Q20203"}], "uniprot_kb": "O14958"}, "pathway": {"kegg": [{"id": "hsa04020", "name": "Calcium signaling pathway - Homo sapiens (human)"}, {"id": "hsa04260", "name": "Cardiac muscle contraction - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-2672351", "name": "Stimuli-sensing channels"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-397014", "name": "Muscle contraction"}, {"id": "R-HSA-5576891", "name": "Cardiac conduction"}, {"id": "R-HSA-5578775", "name": "Ion homeostasis"}, {"id": "R-HSA-983712", "name": "Ion channel transport"}], "wikipathways": {"id": "WP536", "name": "Calcium Regulation in the Cardiac Cell"}}, "pdb": ["2VAF", "6OWV", "6OWW", "7F05"], "pfam": "PF01216", "pharmgkb": "PA26096", "pharos": {"target_id": 12057, "tdl": "Tbio"}, "prosite": "PS51257", "reagent": {"CondMedia_CM_LibrAB": {"id": "GNF292561", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF246819", "relationship": "is"}, {"id": "GNF246820", "relationship": "is"}, {"id": "GNF246821", "relationship": "is"}, {"id": "GNF246822", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF032677", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF080369", "relationship": "is"}, {"id": "GNF080370", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051076", "relationship": "is"}, {"id": "GNF055844", "relationship": "is"}, {"id": "GNF060532", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070155", "relationship": "is"}, {"id": "GNF070156", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF002136", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF337280", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF102401", "relationship": "is"}, {"id": "GNF142055", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_008802.1"], "protein": "NP_001223.2", "rna": "NM_001232.4", "translation": {"protein": "NP_001223.2", "rna": "NM_001232.4"}}, "reporter": {"HG-U133_Plus_2": "207317_s_at", "HG-U95Av2": "36505_at", "HTA-2_0": "TC01003020.hg.1", "HuEx-1_0": "2429556", "HuGene-1_1": "7918878", "HuGene-2_1": "16691333"}, "summary": "The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008].", "symbol": "CASQ2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413135"}, "unigene": "Hs.57975", "uniprot": {"Swiss-Prot": "O14958", "TrEMBL": "A0AA34QVH1"}}